Arli Aditya Parikesit
Arli Aditya Parikesit
Other namesArli Parikesit, Arli Aditya
Professor of Bioinformatics, Indonesia International Institute for Life Sciences
Verified email at - Homepage
Cited by
Cited by
COVID-19 In Silico Drug with Zingiber officinale Natural Product Compound Library Targeting the Mpro Protein
RM Wijaya, MA Hafidzhah, VD Kharisma, ANM Ansori, AA Parikesit
Makara Journal of Science 25 (3), 5, 2021
Severe Acute Respiratory Syndrome Coronavirus-2 Emergence and Its Treatment with Alternative Medicines: A Review
ANM Ansori, VD Kharisma, A Fadholly, MR Tacharina, Y Antonius, ...
Research Journal of Pharmacy and Technology 14 (10), 5551-5557, 2021
Genetic Variant of SARS-CoV-2 Isolates in Indonesia: Spike Glycoprotein Gene
ANM Ansori, VD Kharishma, SS Muttaqin, Y Antonius, AA Parikesit
Journal of Pure and Applied Microbiology 14 (Suppl1), 2020
Bioactive Compounds from Mangosteen (Garcinia mangostana L.) as an Antiviral Agent via Dual Inhibitor Mechanism against SARSCoV-2: An In Silico Approach
ANM Ansori, VD Kharisma, AA Parikesit, FA Dian, RT Probojati, ...
Pharmacognosy Journal 14 (1), 2022
Immunoinformatics approach in designing epitope-based vaccine against meningitis-inducing bacteria (Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae …
H Zahroh, A Ma'rup, USF Tambunan, AA Parikesit
Drug target insights 10, DTI. S38458, 2016
Utilization of Secondary Metabolites in Algae Kappaphycus alvarezii as a Breast Cancer Drug with a Computational Method
AF Dibha, S Wahyuningsih, ANM Ansori, VD Kharisma, MH Widyananda, ...
Pharmacognosy Journal 14 (3), 2022
In silico modification of suberoylanilide hydroxamic acid (SAHA) as potential inhibitor for class II histone deacetylase (HDAC)
USF Tambunan, N Bramantya, AA Parikesit
BMC bioinformatics 12 (13), S23, 2011
Screening of commercial cyclic peptide as inhibitor NS5 methyltransferase of Dengue virus through Molecular Docking and Molecular Dynamics Simulation
USF Tambunan, H Zahroh, BB Utomo, AA Parikesit
Bioinformation 10 (1), 23, 2014
Biological Activity of Kencur (Kaempferia Galanga L.) against SARS-CoV-2 Main Protease: In Silico Study
AF Dibha, S Wahyuningsih, VD Kharisma, ANM Ansori, MH Widyananda, ...
International journal of health sciences 6 (S1), 468-480, 2022
Computational design of disulfide cyclic peptide as potential inhibitor of complex NS2B-NS3 dengue virus protease
USF Tambunan, N Apriyanti, AA Parikesit, W Chua, K Wuryani
African Journal of Biotechnology 10 (57), 12281-12290, 2011
Screening of commercial cyclic peptides as inhibitor envelope protein dengue virus (DENV) through molecular docking and molecular dynamics
AA Parikesit, USF Tambunan
Pakistan Journal of Biological Sciences 16 (24), 1836, 2013
In silico analysis of envelope Dengue Virus-2 and envelope Dengue Virus-3 protein as the backbone of Dengue Virus tetravalent vaccine by using homology modeling method
US Friend, AA Parikesit, RI Taufik, F Amelia
OnLine Journal of Biological Sciences 9 (1), 6-16, 2009
Molecular simulation of compounds from n-hexane fraction of Sonchus arvensis L. leaves as SARS-CoV-2 antiviral through inhibitor activity targeting strategic viral protein
DK Wahyuni, S Wacharasindhu, W Bankeeree, H Punnapayak, ...
Journal of Pharmacy & Pharmacognosy Research 10 (6), 1126-1138, 2022
Screening of commercial cyclic peptide conjugated to HIV-1 Tat peptide as inhibitor of N-terminal heptad repeat glycoprotein-2 ectodomain Ebola virus through in silico analysis
USF Tambunan, AH Alkaff, MAF Nasution, AA Parikesit, D Kerami
Journal of Molecular Graphics and Modelling 74, 366-378, 2017
Screening Analogs of β-OG Pocket Binder as Fusion Inhibitor of Dengue Virus 2.
US Tambunan, H Zahroh, AA Parikesit, S Idrus, D Kerami
Drug target insights 9, 33-49, 2014
Modification of-Adenosyl--Homocysteine as Inhibitor of Nonstructural Protein 5 Methyltransferase Dengue Virus Through Molecular Docking and Molecular Dynamics Simulation
USF Tambunan, MAF Nasution, F Azhima, AA Parikesit, EP Toepak, ...
Drug Target Insights 2017 (11), 0-0, 2017
Natural products repurposing of the H5N1-based lead compounds for the most fit inhibitors against 3C-like protease of SARS-CoV-2
AA Parikesit, R Nurdiansyah
Journal of Pharmacy & Pharmacognosy Research 9 (5), 730-745, 2021
In silico design of cyclic peptides as influenza virus, a subtype H1N1 neuraminidase inhibitor
USF Tambunan, N Amri, AA Parikesit
African Journal of Biotechnology 11 (52), 11474-11491, 2012
The whole-genome sequencing in predicting Mycobacterium tuberculosis drug susceptibility and resistance in Papua, Indonesia
Y Maladan, H Krismawati, T Wahyuni, R Tanjung, K Awaludin, KA Audah, ...
BMC genomics 22 (1), 1-11, 2021
Vaccine design for H5N1 based on B-and T-cell epitope predictions
USF Tambunan, FRP Sipahutar, AA Parikesit, D Kerami
Bioinformatics and Biology insights 10, BBI. S38378, 2016
The system can't perform the operation now. Try again later.
Articles 1–20